Efficacy and Safety of Dapagliflozin in Preventing Atrial Fibrillation Recurrence After Catheter Ablation
Clinical trial NCT06740786 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06740786
- Sponsor
- Xu Liu
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-10
- Primary completion
- 2026-05-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.